Stay updated on Dupilumab in Pediatric Peanut Allergy Clinical Trial

Sign up to get notified when there's something new on the Dupilumab in Pediatric Peanut Allergy Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Dupilumab in Pediatric Peanut Allergy Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The page now displays the ClinicalTrials.gov record for a completed Phase 2 study of dupilumab in children with peanut allergy, including eligibility, study outcomes, results-related details, and study documents.
    Difference
    54%
    Check dated 2026-11-09T04:18:47.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.2 to v3.8.0. The page still shows a 403 Forbidden message instead of the study record.
    Difference
    0.2%
    Check dated 2026-11-02T02:51:46.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    A sitewide banner announces an NIH website transition and says federal agencies are using “Super Intelligence” in place of “Artificial Intelligence” during the transition.
    Difference
    1%
    Check dated 2026-10-26T03:56:34.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    The footer revision identifier changes from v3.7.1 to v3.7.2, while the page continues to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-19T03:18:06.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    The revision label in the footer changes from v3.7.0 to v3.7.1 on the 403 Forbidden page.
    Difference
    0.2%
    Check dated 2026-10-12T03:18:42.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    Access to the study record is blocked by a 403 Forbidden page, replacing the page content with an error screen. This prevents viewing details such as study status, locations, contacts, and related information.
    Difference
    18%
    Check dated 2026-09-21T00:54:02.000Z thumbnail image

Stay in the know with updates to Dupilumab in Pediatric Peanut Allergy Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Dupilumab in Pediatric Peanut Allergy Clinical Trial page.